The Palico Private Equity Fund Marketplace
TPG Biotech is a private equity general partner firm headquartered in San Francisco, CA, United States.
CA-based clinical-stage pharmaceutical company Adynxx has closed a $16m Series B round from TPG Biotech and Domain Associates.
Leader in developing best-in-class therapies firm Satsuma Pharmaceuticals has raised $12m in Series A from RA Capital Management and others.
Israel-based Nutrinia, an insulin developer for infants, has raised $30m in Series D funding led by TPG Biotech.
Read more news concerning TPG Biotech
A sampling of TPG Biotech portfolio companies:
View all of the investments in their portfolio
This firm also pursues other investment strategies:
Registration is fast, free and easy
Already a member?